Novel agents and methods for treatment and diagnosis of ocular disorders
CA 2348488 C · Owner: The Flinders University Of South Australia · Inventors: Thiel, Michael Alexander; Williams, Keryn Anne; Coster, Douglas John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of treating an ocular disorder is disclosed comprising administering , to a patient in need of such treatment an effective , amount of a sub-immunoglobulin antigen-binding molecule that is immunointeractive with a target antigen associated with the disorder. The invention is also directed to compositions comprising this subimmunoglobulin antigen-binding molecule and to a method of diagnosing an ocular condition using such molecule.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 24, 1999 and granted March 1, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 24, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 24, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.